Tissue Regenix Group PLC (LSE:TRX) - Share price

Stock Report

Tissue Regenix Group PLC TRX

Latest Morningstar Commentary
DateAuthor Headline

Latest Company News

Previous Stories...
07/10/202013:50DGAPHardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
28/09/202012:24LSEHoldings in CompanyHOL
16/09/202007:42LSEHoldings in CompanyHOL
15/09/202016:40LSESecond Price Monitoring ExtnAPM
15/09/202016:35LSEPrice Monitoring ExtensionPME
14/09/202017:33LSEHoldings in CompanyHOL
02/09/202007:00LSEUnaudited Interim ResultsIR
27/08/202007:00LSENotice of Interim Results & Investor PresentationNOR
24/08/202007:00LSEUK distribution partner for OrthoPure® XTCNT
18/08/202011:27LSEHoldings in CompanyHOL
17/08/202007:00LSERelocation of UK office and manufacturing facilityMSC
27/07/202009:59LSEHoldings in CompanyHOL
24/07/202007:00LSECommencement of facility expansion planMSC
23/07/202018:22LSEHoldings in CompanyHOL
17/07/202009:56LSEHoldings in CompanyHOL
10/07/202015:18LSEHoldings in CompanyHOL
06/07/202009:31LSEHoldings in CompanyHOL
03/07/202010:01LSEHoldings in CompanyHOL
30/06/202016:44LSETotal Voting RightsTVR
30/06/202010:42LSEResult of AGMRAG
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.